ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 189.00
+7.50 (4.13%)
Aug 26, 2026, 1:48 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 12.93 billion as of August 25, 2026. Its market cap has increased by 155.94% in one year.
Market Cap
12.93B
Enterprise Value
12.04B
Revenue
52.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
189.00
ChartMarket Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 12.93B, an increase of 1,204.85%. That is a compound annual growth rate of 65.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 12.93B | 219.92% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 22.82B |
| Sunmax Biotechnology | 21.84B |
| Medigen Vaccine Biologics | 18.51B |
| TaiMed Biologics | 17.40B |
| Ever Supreme Bio Technology | 15.88B |
| EirGenix | 15.23B |
| Gongwin Biopharm Holdings | 13.45B |
| Lumosa Therapeutics | 12.98B |